Journal article
Multi-omics reveal vitamin D regulation of immune-gut microbiome interactions and tolerogenic pathways in inflammatory bowel disease
J Gubatan, RS Sojwal, J Ye, TL Boye, JN Hoang, T Fardeen, M Temby, SJS Rubin, SP Spencer, P Kotagiri, S Rogalla, MJ Rosen, OH Nielsen, S Boyd, J Sonnenburg, SR Sinha
Cell Reports Medicine | Published : 2026
Open access
Abstract
Loss of immune tolerance to the gut microbiome plays a pathogenic role in inflammatory bowel disease (IBD). How dietary factors alter host immune-gut microbiome interactions in IBD is unclear. Here, we apply multi-omics (immunoglobulin A or G and 16S rRNA sequencing [IgA-seq, IgG-seq], blood single-cell RNA sequencing [scRNA-seq], and immune repertoire sequencing) to investigate the effects of 12 weeks of vitamin D on host immune microbe interactions in patients with IBD. Vitamin D treatment associates with decreased disease activity and inflammatory markers and increased IgA-bound and decreased IgG-bound gut microbiota. Vitamin D alters the profiles of IgA-bound (increased Lachnospiraceae, ..
View full abstractGrants
Awarded by NIDDK NIH HHS